Safety and Efficacy of Simultaneous or Staged Surgery on Complicated Hepatolithiasis
A Cohort Study on Safety and Efficacy of Simultaneous or Staged Surgery in Complicated Hepatolithiasis
1 other identifier
interventional
92
1 country
1
Brief Summary
For some complicated hepatolithiasis, it is difficult to decide whether to perform surgery on biliary stone and portal hypertension simultaneously or separately by staged surgery.There's a high risk of intraoperative bleeding, postoperative liver failure and variceal bleeding for these patients.How to develop a optimized algorism of simultaneous and staged surgery is highly needed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2017
CompletedFirst Posted
Study publicly available on registry
March 31, 2017
CompletedStudy Start
First participant enrolled
April 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedApril 12, 2017
April 1, 2017
1.7 years
March 20, 2017
April 11, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
residual ratio of biliary stone
residual ratio of biliary stone diagnosed within 3 months
3 months
Secondary Outcomes (4)
postoperative complications
6 months
residual lesions
6 months
Health economics index
3 months
mortality
3 months
Study Arms (2)
Simultaneous surgery
EXPERIMENTALto perform surgery both on biliary stone and portal hypertension
Staged surgery
ACTIVE COMPARATORto perform surgery on biliary stone and portal hypertension by staged surgery
Interventions
Simultaneous surgery in complicated hepatolithiasis
Eligibility Criteria
You may qualify if:
- Aged from 18 to 65 years old
- Without gender restriction
- With a favorable liver function of Child-Pugh A to B
- No contraindications to surgery and anesthesia
- Diagnosed with Hepatolithiasis and portal hypertension
- Signed informed consent.
You may not qualify if:
- Diffused type of Hepatolithiasis
- Impairment in liver function
- Severe disorders in vital organ
- Accompanied with tumors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Southwest Hospital, Chinalead
- Second Affiliated Hospital, School of Medicine, Zhejiang Universitycollaborator
- Chinese PLA General Hospitalcollaborator
- Eastern Hepatobiliary Surgery Hospitalcollaborator
- First Affiliated Hospital of Zhongshan Medical Universitycollaborator
- Air Force Military Medical University, Chinacollaborator
- Huaxi Hospitalcollaborator
- Tongji Hospitalcollaborator
- Union hospital of Fujian Medical Universitycollaborator
Study Sites (1)
Southwest Hospital
Chongqing, Chongqing Municipality, 400038, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
March 20, 2017
First Posted
March 31, 2017
Study Start
April 11, 2017
Primary Completion
December 30, 2018
Study Completion
December 31, 2018
Last Updated
April 12, 2017
Record last verified: 2017-04